FORBES-TATE

Lobbying for TARSUS PHARMACEUTICALS · Life sciences product developer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 17, 2026

Lobbying activity 1

Health Issues

Issues related to education and advocacy pertaining to life science products and pipeline.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.